• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [20829 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2005     HAYES, Inc. Small bowel, small bowel-liver, and multivisceral transplantation
2021     Adelaide Health Technology Assessment (AHTA) Small gene panel testing for NSCLC
2001     Washington Singer Press Small Voices Big Noises: Lay involvement in health research:lessons from other fields
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Smart infusion pump use in hospitalized patients: clinical safety and guidelines
2013     NIHR Horizon Scanning Centre (NIHR HSC) Smart-Glasses depth-based visual aids for the partially sighted
2006     NIHR Horizon Scanning Centre (NIHR HSC) Smartinhaler for personal asthma management: horizon scanning technology briefing
2007     Adelaide Health Technology Assessment (AHTA) Smartinhaler™ with audiovisual reminder for asthma medication
2010     HAYES, Inc. SmartPill GI monitoring system (SmartPill Corp.) for diagnosis of gastroparesis and monitoring of intestinal motility
2013     NIHR Horizon Scanning Centre (NIHR HSC) SmartSensor electronic oral glucose tolerance test for screening for diabetes
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) SmartSite bag access device: safety
2009     Penn Medicine Center for Evidence-based Practice (CEP) Smoking cessation for inpatients
2012     Medical Advisory Secretariat (MAS) Smoking cessation for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis
2014     HAYES, Inc. Smoking cessation in patients with schizophrenia
2015     NIHR Health Technology Assessment programme Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Smoking cessation interventions for pregnant women and mothers of infants: a review of the clinical effectiveness, safety, and guidelines
2004     Danish Institute for Health Services Research (DSI) Smoking cessation interventions in pharmacies. Demand from smokers and the ability of general practitioners to recruit participants
2014     Agency for Healthcare Research and Quality (AHRQ) Smoking cessation interventions in pregnancy and postpartum care
2021     NIHR Health Technology Assessment programme Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis
1998     The Swedish Council on Health Technology Assessment (SBU) Smoking cessation methods
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Smoking cessation prior to surgery: clinical evidence
2008     National Institute for Health and Clinical Excellence (NICE) Smoking cessation services in primary care, pharmacies, local authorities and workplaces, particularly for manual working groups, pregnant women and hard to reach communities
2001     University HealthSystem Consortium (UHC) Smoking cessation therapies
1998     University of York Smoking cessation: what the health service can do
2011     HAYES, Inc. SNaP wound care system (Spiracur Inc.) for treatment of lower extremity ulcers
2012     HAYES, Inc. SNaP wound care system (Spiracur Inc.) for treatment of lower extremity ulcers
2001     Institute of Technology Assessment (ITA) Social implications of the increasing spread of technology in medicine
2008     Medical Advisory Secretariat (MAS) Social isolation in community-dwelling seniors: an evidence-based analysis
2014     Penn Medicine Center for Evidence-based Practice (CEP) Social media, text messaging, and post-discharge communication
2020     NIHR Health Services and Delivery Research programme Social norms interventions to change clinical behaviour in health workers: a systematic review and meta-analysis
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Social return on investment: outcomes, methods, and economic parameters
2011     HAYES, Inc. Social skills training for autistic spectrum disorders
2016     NIHR Health Technology Assessment programme Social Stories to alleviate challenging behaviour and social difficulties exhibited by children with autism spectrum disorder in mainstream schools: design of a manualised training toolkit and feasibility study for a cluster randomised controlled trial with nested qualitative and cost-effectiveness components
2016     Penn Medicine Center for Evidence-based Practice (CEP) Social work support following distress screening in oncology care
2003     Center for Medical Technology Assessment (CMT) Societal costs of rheumatic diseases
2020     NIHR Health Technology Assessment programme Sodium bicarbonate to improve physical function in patients over 60 years with advanced chronic kidney disease: the BiCARB RCT
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Sodium chloride inhalation for the treatment of cystic fibrosis: a review of the clinical evidence, cost-effectiveness and guidelines
2009     HAYES, Inc. Sodium hyaluronate for osteoarthritis
2004     HAYES, Inc. Sodium hyaluronate for osteoarthritis
2004     NIHR Horizon Scanning Centre (NIHR HSC) Sodium oxybate (Xyrem) for cataplexy and excessive daytime sleepiness in narcolepsy - horizon scanning review
2009     NIHR Horizon Scanning Centre (NIHR HSC) Sodium oxybate (Xyrem) for fibromyalgia - first line
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sodium phenylbutyrate (Pheburane®)
2015     Health Quality Ontario (HQO) Sodium restriction in heart failure: a rapid review
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sodium thiosulfate for prevention of hearing loss in children receiving cisplatin chemotherapy
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sodium valproate (Episenta®)
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sodium Zirconium cyclosilicate for hyperkalaemia – first line
2022     Agency for Care Effectiveness (ACE) Sodium zirconium cyclosilicate for treating hyperkalaemia
2020     Agency for Care Effectiveness (ACE) Sodium-glucose co-transporter 2 (SGLT2) inhibitors for type 2 diabetes mellitus
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Sofosbuvir (Sovaldi — Gilead Sciences Canada, Inc.) indication: chronic hepatitis C infection
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir (Sovaldi) with GS-5816 for chronic hepatitis C
2012     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir for chronic hepatitis C infection with compensated liver disease
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Sofosbuvir for the treatment of patients with genotype 4 hepatitis C: a review of the clinical efficacy, cost-effectiveness, and guidelines
2014     NIHR Health Technology Assessment programme Sofosbuvir for treating chronic hepatitis C
2013     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir with ledipasvir for hepatitis C, genotype 1
2016     HAYES, Inc. Sofosbuvir-velpatasvir for chronic HCV infection
2016     NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir, GS-9857 and velpatasvir triple therapy for chronic hepatitis C
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Soft tissue augmentation for HIV patients with lipodystrophy syndrome
2014     NIHR Horizon Scanning Centre (NIHR HSC) SoftVue™ system for diagnostic breast imaging
2005     Adelaide Health Technology Assessment (AHTA) Solar Scan (R) for the detection and monitoring of melanoma
2014     HAYES, Inc. Solesta (NASHA Dx; Q-Med AB) for treatment of fecal incontinence
2013     HAYES, Inc. Solesta (Q-Med AB) for treatment of fecal incontinence
2012     HAYES, Inc. Solesta (Q-Med AB) for treatment of fecal incontinence
2010     Medical Advisory Secretariat (MAS) Solid organ transplantation for End Stage Organ Failure (ESOF) in persons with HIV
2018     Agency for Care Effectiveness (ACE) Solifenacin for treating overactive bladder
2021     European Network for Health Technology Assessment (EUnetHTA) Solnatide for the treatment of COVID-19
1999     University HealthSystem Consortium (UHC) Solvent/detergent-treated plasma
1999     Centre for Technology Assessment at the Swiss Science and Technology Council (TA-SWISS) Somatic gene therapy: striking to the roots of disease (Short version of the TA study 'Gene therapy')
2006     HAYES, Inc. Somatosensory evoked potentials (SEPs) for intraoperative monitoring (IOM) during surgery for scoliosis
2012     HAYES, Inc. Somatosensory evoked potentials (SEPs) for intraoperative monitoring during spinal cord surgery for trauma or tumors
2006     HAYES, Inc. Somatosensory evoked potentials for prognosis of coma following cardiac arrest
2006     HAYES, Inc. Somatostatin receptor scintigraphy (SRS) for localization of neuroendocrine tumors and their metastases
1996     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Somatostatin receptor scintigraphy (systematic review, expert panel)
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin (Genotropin - Pfizer Canada Inc.) indication: growth hormone deficiency in adults
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin (Genotropin - Pfizer Canada Inc.) indication: long-term treatment of children who have growth failure due to an inadequate secretion of endogenous growth hormone
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Somatropin (Genotropin - Pfizer Canada Inc.) indication: Turner syndrome
2017     Agency for Care Effectiveness (ACE) Somatropin for the treatment of growth failure in children
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Somnoplasty (R) system
2015     NIHR Horizon Scanning Centre (NIHR HSC) Sonata™ System for the removal of uterine fibroids
2005     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Sonographic diagnosis of acute abdomen in children and adults
2015     HAYES, Inc. Sonohysterography for assessment of abnormal uterine bleeding
2005     Adelaide Health Technology Assessment (AHTA) SonoPrep (R) Ultrasonic Skin Permeation system for skin preparation prior to cutaneous penetration
2005     New Zealand Health Technology Assessment (NZHTA) SonoPrep ultrasonic skin permeation system
2007     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) for advanced non-small cell lung cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) for hepatocellular carcinoma - adjuvant therapy
2007     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) for hepatocellular carcinoma: horizon scanning technology briefing
2011     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) in combination with capecitabine for HER2-negative locally advanced or metastatic breast cancer - second line
2016     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sorafenib (Nexavar®)
2006     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib for advanced hepatocellular carcinoma (HCC): horizon scanning review
2010     NIHR Health Technology Assessment programme Sorafenib for the treatment of advanced hepatocellular carcinoma
2010     National Institute for Health and Clinical Excellence (NICE) Sorafenib for the treatment of advanced hepatocellular carcinoma
2006     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib tosylate (nexavar) for advanced renal cell carcinoma: horizon scanning review
2019     European Network for Health Technology Assessment (EUnetHTA) Sotagliflozin indicated as an adjunct to insulin therapy to improve glycaemic control in adults with type 1 diabetes mellitus with a Body Mass Index (BMI) ≥ 27 kg/m2, who have failed to achieve adequate glycaemic control despite optimal insulin therapy
2011     NIHR Horizon Scanning Centre (NIHR HSC) Soundbite hearing system
2014     HAYES, Inc. SoundBite hearing system (Sonitus Medical Inc.) for treatment of unilateral hearing loss
2014     NIHR Horizon Scanning Centre (NIHR HSC) SpaceOAR® perirectal spacing system for prostate cancer radiation
2012     NIHR Horizon Scanning Centre (NIHR HSC) Spartan RX™ point-of-care DNA test for identifying the CYP2C19*2 mutation
2022     Institute for Clinical and Economic Review (ICER) Special assessment of outpatient treatments for COVID-19
1992     U. S. Congress. Office of Technology Assessment (OTA) Special care units for people with Alzheimer's and other dementias: consumer education, research, regulatory and reimbursement issues
2008     Blue Cross Blue Shield Association (BCBS) Special report: aCGH for the genetic evaluation of patients with developmental delay/mental retardation or autism spectrum disorder
2007     Blue Cross Blue Shield Association (BCBS) Special report: cardiovascular pharmacogenomics
2015     Blue Cross Blue Shield Association (BCBS) Special report: chromosomal microarray for the genetic evaluation of patients with global developmental delay, intellectual disability, and autism spectrum disorder